Skip to main content
VCbacked
Log inGet Started

CNS Pharmaceutical

Houston, United States

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

$22.5M raised
May 2026
Post-IPO Equity
BiotechnologyLife SciencePharmaceuticalTherapeutics

Top Investors

Nazare PartnersADAR1 Capital ManagementStonepine Capital ManagementIkarian Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CNS Pharmaceutical

How much funding has CNS Pharmaceutical raised?
CNS Pharmaceutical has raised $22.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Who are CNS Pharmaceutical's investors?
CNS Pharmaceutical's investors include Nazare Partners, ADAR1 Capital Management, Stonepine Capital Management, Ikarian Capital.
Where is CNS Pharmaceutical headquartered?
CNS Pharmaceutical is headquartered in Houston, United States.
What does CNS Pharmaceutical do?
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
What stage is CNS Pharmaceutical at?
CNS Pharmaceutical is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CNS Pharmaceutical — Funding & Investors." VCBacked, May 4, 2026, https://www.vcbacked.co/company/cns-pharmaceutical. Accessed July 2, 2026.
APA
VCBacked. (2026). CNS Pharmaceutical — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cns-pharmaceutical
Wikipedia (cite web)
{{cite web |title=CNS Pharmaceutical — Funding & Investors |url=https://www.vcbacked.co/company/cns-pharmaceutical |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K